Henry Fahman, CEO of Phi Group, inc.- OTCPink: $PHIL - Does Live Interview on theStockRadio.com
TheStockRadio.com is widely recognized for bringing the small-cap investing community a solid source for fund managers, angel investors, hedge funds and retail investors their first step in conducting their due diligence for emerging growth opportunities.
Our latest interview with CEO Henry Fahman, from PHI Group, Inc. (OTC Pink: PHIL) is an example of an emerging growth company that has a lot of room to grow and is taking all the right steps in the right direction. With a solid management team and board of directors that is second to none, PHI Group, inc. (OTC Pink: PHIL) CEO Henry Fahman goes into a lot of detail as to their current situation and future plans of expansion
The interview can be found here:
TheStockRadio.com is widely recognized for bringing the small-cap investing community a solid source for fund managers, angel investors, hedge funds and retail investors their first step in conducting their due diligence for emerging growth opportunities.
Our latest interview with CEO Robert Schneiderman, from ScripsAmerica, Inc. (otcqb:SCRC) is an example of an emerging growth company that has a lot of room to grow and is taking all the right steps in the right direction. With a solid management team and board of directors that is second to none, ScriptsAmerica (otcqb:SCRC) CEO Robert Schneiderman goes into a lot of detail as to their Q3 results, Rapimed, their diabetes program, and much more.
The interview can be found here: http://thestockradio.com/audio-interview-henry-fahman-ceo-of-phi-group-otc-phil-2613.html
PHI Group, inc. (OTC: PHIL) trades in the same sector as Peabody Energy (BTU), Arch Coal (ACI), Alpha Natural Resources (ANR), Cloud Peak Energy (CLD)
For more information about the Stock Radio please visit our website located at:http://theStockRadio.com.
About TheStockRadio.com
TheStockRadio is a small-cap research and investment commentary provider. TheStockRadio.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on TheStockRadio please visit http://thestockradio.com.
U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
